Ribomed Biotechnologies, Inc.
Carlsbad, CA · Medtech · Defunct
Noninvasive diagnostic test for endometriosis based on DNA methylation biomarkers using the MethylMeter platform and CAPS (Coupled Abscription PCR Signaling) technology
- Grants
- $164K
- 1 award
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $603K
- 3 awards · Defense, Health and Human S
- #370 of 4531 in medtech
- Patents
- 8
- 0 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2001200320052007200920112013201520172019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal contract | Department of Defense | $211,047 | |
| Federal contract | Department of Defense | $247,170 | |
| Federal contract | Department of Health and Human Services · SBIR Topic 264 (phase 1) - The Objective Of This Project Is To Develop Kits That Can Be Used To Analyze The Methylation Status Of Several Different Cpg Islands In A Single Sample Without Bisulfite Treatment. | $145,124 | |
| Federal grant | Department of Health and Human Services · Phase I · Non-Invasive Assay for Diagnosis and Treatment of Endometriosis | $164,306 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 367 | Medigus | $623K | $8.6M |
| 368 | Sentien Biotechnologies, Inc. | $610K | $1.0M |
| 369 | PGXL TECHNOLOGIES LLC | $606K | — |
| 370 | Ribomed Biotechnologies, Inc. | $603K | — |
| 371 | SONATA SCIENTIFIC LLC | $600K | — |
| 372 | BIG EYE DIAGNOSTICS INC | $600K | — |
| 373 | AO TECHNOLOGIES, LLC | $597K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- ABORTIVE PROMOTER CASSETTES AND METHODS FOR FUSION TO TARGETS AND QUANTITATIVE CpG ISLAND METHYLATION DETECTION USING THE SAMEapplication
- Abortive Promoter Cassettes And Methods For Fusion To Targets And Quantitative Cpg Island Methylation Detectionapplication
- Abscription Based Molecular Detectionapplication
- Molecular Beacon-based Methods For Detection Of Targets Using Abscriptionapplication
- Methods And Reagents For Detecting Cpg Methylation With A Methyl Cpg Binding Protein (mbp)application
- Compositions, Methods And Detection Technologies For Reiterative Oligonucleotide Synthesisapplication
- Molecular Detection Systems Utilizing Reiterative Oligonucleotide Synthesisapplication
- Molecular Detection Systems Utilizing Reiterative Oligonucleotide Synthesisapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.